Tuesday, September 2, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Triglyceride-Glucose Index Linked to Hypertension in Cancer

June 4, 2025
in Cancer
Reading Time: 4 mins read
0
66
SHARES
597
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking study published in BMC Cancer, researchers have unveiled a significant link between the triglyceride-glucose (TyG) index and hypertension among adults diagnosed with cancer. This association sheds new light on the complex interplay between metabolic dysfunction and cardiovascular complications in oncological populations. The findings offer a promising biomarker to better predict and manage hypertension, one of the leading comorbidities exacerbating cancer patients’ overall prognosis.

Hypertension, a chronic condition characterized by elevated blood pressure, is a major risk factor for cardiovascular disease and mortality worldwide. Its development has been closely connected to insulin resistance (IR), a metabolic state where cells fail to respond properly to insulin, thereby impairing glucose regulation. Conventional methods of diagnosing IR are often invasive or costly, highlighting the need for alternative, accessible markers. The TyG index, calculated using routine fasting triglyceride and glucose levels, emerges as a convenient and reliable surrogate biomarker for assessing IR.

This comprehensive cross-sectional study leveraged data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2005 to 2018. The cohort comprised 1,222 adults with a documented history of cancer. These subjects underwent thorough evaluation including demographic profiling, medical history assessment, lifestyle analysis, and laboratory testing, with a particular focus on the TyG index and blood pressure measurements.

Notably, more than half of the participants—56.29%, or 775 individuals—were diagnosed with hypertension, underscoring the high prevalence of cardiovascular burden within this vulnerable group. The researchers employed multivariable logistic regression models to control for confounding factors, ensuring the robustness of the observed associations. The adjusted analyses revealed that for each incremental increase in the TyG index, the odds of hypertension development rose significantly.

Analyzing the TyG index as a continuous variable, the study found an odds ratio (OR) of 1.51 (95% CI: 1.09–2.11; p = 0.015), indicating a 51% increase in hypertension risk per unit rise in TyG. When categorizing the population into quartiles based on TyG values, a clear gradient in hypertension prevalence emerged. Participants in the highest TyG quartile exhibited an OR of 1.68 (95% CI: 1.09–2.84; p = 0.041) relative to the lowest quartile, highlighting a dose-response relationship.

Further stratified analyses dissected the data across various demographic and socioeconomic variables including age, sex, marital status, educational attainment, and family income levels. Intriguingly, none of these subgroup analyses revealed significant interaction effects, implying that the TyG-hypertension relationship persists consistently across diverse population segments. This homogeneity strengthens the argument for TyG’s utility as a universal risk indicator in cancer patients.

To characterize the nature of the TyG–hypertension association, the team utilized restricted cubic splines (RCS), an advanced statistical method allowing for the detection of potential nonlinear patterns. The spline analysis confirmed a predominantly linear relationship between TyG index values and hypertension prevalence, suggesting that incremental increases in TyG continuously elevate hypertension risk without plateauing or threshold effects.

From a mechanistic standpoint, elevated TyG levels reflect a state of insulin resistance intertwined with lipid metabolism disturbances and chronic inflammation—processes intrinsically linked to endothelial dysfunction and heightened vascular resistance. Cancer itself may exacerbate these metabolic derangements either directly via tumor biology or indirectly through treatment-related side effects, amplifying susceptibility to hypertensive conditions.

The study’s findings herald significant clinical implications. Routine monitoring of the TyG index in adults with cancer could enable early identification of individuals at elevated hypertension risk, facilitating timely preventive interventions. Given hypertension’s well-established role in compromising cancer treatment outcomes and survival, integrating metabolic marker evaluation into oncological care paradigms may represent a vital step toward comprehensive patient management.

Moreover, these results invite further exploration into whether therapeutic strategies targeting insulin resistance might concomitantly ameliorate hypertensive sequelae among cancer patients. Lifestyle modifications, such as dietary optimization and physical activity, alongside pharmacological approaches addressing glucose and lipid abnormalities, could theoretically attenuate the TyG index and its associated cardiovascular risks.

It is important to acknowledge that the cross-sectional design of the NHANES dataset limits causal inference. Longitudinal studies are warranted to validate these associations prospectively and consider temporal dynamics between metabolic changes and hypertension onset. Additionally, dissecting cancer subtype-specific variations and treatment modalities could yield finer granularity in understanding these complex interactions.

Despite these limitations, the research breaks new ground by illuminating a novel, metabolic pathway linking insulin resistance and cardiovascular disease in an understudied population. Cancer survivors constitute an expanding demographic globally, often burdened by multiple co-morbidities that diminish quality of life. Identifying accessible risk markers such as the TyG index empowers clinicians to tailor interventions that address both oncological and cardiovascular health.

This study adds a critical piece to the intricate puzzle of cancer-related comorbidities, exemplifying how metabolic health parameters may serve dual roles in disease processes and prognostication. The TyG index, derived from inexpensive routine laboratory measures, offers a scalable approach for widespread clinical adoption and public health monitoring.

Future research directions may encompass exploring the molecular underpinnings connecting triglyceride-glucose dysregulation to vascular stiffness and hypertension pathophysiology in cancer settings. Integration of genetic, epigenetic, and metabolomic data could unravel personalized risk profiles, informing precision medicine approaches.

In conclusion, elevated TyG index levels correlate strongly and linearly with increased hypertension risk in adults afflicted with cancer, independent of demographic and socioeconomic factors. This discovery portends a promising avenue for improved cardiovascular risk stratification and underscores the imperative for metabolic evaluation in comprehensive cancer care frameworks.

As the oncology and cardiovascular research fields converge, multidimensional assessments incorporating biochemical markers like TyG could revolutionize both prediction and management strategies, ultimately enhancing survivorship trajectories and patient outcomes.


Subject of Research: Association between triglyceride-glucose index and hypertension in adults with cancer

Article Title: Association between triglyceride-glucose index and hypertension in adults with cancer from NHANES 2005–2018: a cross-sectional study

Article References:
Li, G., Zhang, D., Li, M. et al. Association between triglyceride-glucose index and hypertension in adults with cancer from NHANES 2005–2018: a cross-sectional study. BMC Cancer 25, 993 (2025). https://doi.org/10.1186/s12885-025-14398-0

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14398-0

Tags: adult cancer patient health evaluationbiomarker for hypertension managementcancer comorbidities and mortalitycancer-related cardiovascular complicationscardiovascular disease risk factors in cancerchronic hypertension in oncologyinsulin resistance and cancer prognosismetabolic dysfunction in cancer patientsNHANES study on cancer and hypertensionnon-invasive methods for insulin resistance assessmenttriglyceride and glucose levels correlationtriglyceride-glucose index and hypertension
Share26Tweet17
Previous Post

Postpartum Depression Treatment Patterns in US

Next Post

Monoclonal Antibody Reduces Hospitalizations for Bronchiolitis by 50% in Infants Under Six Months

Related Posts

blank
Cancer

MRI Radiomics and Tumor Microenvironment in Cervical Cancer

September 2, 2025
blank
Cancer

New Study Highlights Global Disparities in Cancer Research Funding

September 1, 2025
blank
Cancer

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

September 1, 2025
blank
Cancer

Evaluating Diffuse Large B-Cell Lymphoma in Chinese Youth

September 1, 2025
blank
Cancer

DNA-Wrapped Nanoparticles Triple CRISPR’s Efficiency

September 1, 2025
blank
Cancer

Targeting Nrf2 in AML: Combating Chemoresistance

September 1, 2025
Next Post
blank

Monoclonal Antibody Reduces Hospitalizations for Bronchiolitis by 50% in Infants Under Six Months

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27543 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    957 shares
    Share 383 Tweet 239
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    509 shares
    Share 204 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Diabetic Kidney Disease in Ethiopian Type 2 Diabetes
  • Trends in BMI Affect Glycemic Control in Finnish Diabetics
  • Trends and Drivers of PM2.5 and O3 in Shandong
  • Biochar Innovations: Heavy Metal Cleanup and Applications

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading